The popularity of the obesity drug Wegovy has led US employers to rethink insurance coverage

A selection of injector pens for the weight loss drug Wegovy are shown in this photo illustration in Chicago, Illinois, U.S. March 31, 2023. REUTERS/Jim Vondruska/Illustration

June 27 (Reuters) – Shawnte struggled with her weight for years before being prescribed Novo Nordisks’ anti-diabetic drug Ozempic for weight loss in 2020, helping the former New York music industry pro lose more of 50 kilos in two years. But last year, the 46-year-old, who asked to be identified only by her first name … Read more

KFF survey shows complexity, bureaucracy, denials, confusion rivaling affordability as an issue for insured consumers, with some saying it has led them to opt out or delay care

KFF survey shows complexity, bureaucracy, denials, confusion rivaling affordability as an issue for insured consumers, with some saying it has led them to opt out or delay care

KFF survey shows complexity, bureaucracy, denials, confusion rivaling affordability as an issue for insured consumers, with some saying it has led them to opt out or delay care The majority (58%) of people with health insurance say they have experienced at least one problem using their coverage in the past year, with even higher shares … Read more